Meta-Analysis
Feb 18
Claudio Laudani, Davide Capodanno, et al.
In patients with acute myocardial infarction and multivessel coronary artery disease, immediate complete revascularization, whether angiographically or functionally guided, reduces recurrent myocardial infarction and repeat revascularization compared to infarct-related artery-only revascularization and staged complete revascularization.
Editorial
Feb 20
Pieter C. Smits, Valeria Paradies
A network meta-analysis found that complete revascularization, whether angiography- or physiology-guided, reduces recurrent myocardial infarction compared to culprit-only revascularization in STEMI patients.
free
NEW ISSUE
Feb 17
This issue of EuroIntervention brings you a meta-analysis on the completeness, timing and guidance of revascularisation strategies for myocardial infarction and multivessel coronary artery disease; original research looking at whether the assessment of non-culprit lesions by OCT or μQFR offers the best prognostic value for acute myocardial infarction patients; a large nationwide Korean study on the impact of proton pump inhibitors in post-myocardial infarction patients on dual antiplatelet therapy; and a research correspondence on a novel method for risk stratification concerning plaque vulnerability looking at radial wall strain in carotid plaques. There is also news from the EAPCI; and more.
.jpg)
Editorial
Feb 14
Nieves Gonzalo, Marco Lombardi
A subanalysis of the FLAVOUR trial found that FFR and IVUS offer comparable outcomes in guiding PCI for intermediate low-complexity coronary lesions, regardless of diabetic status.
free
Original Research
Feb 13
Sung Woo Cho, Joon-Hyung Doh, et al.
In patients with intermediate coronary stenosis and low lesion complexity, FFR guidance had no significant differences in MACE or TVF, with a lower frequency of PCI compared to IVUS guidance, regardless of diabetes status.
Editorial
Feb 11
Ziad A. Ali, Gregg W. Stone, et al.
This content discusses the utility of intracoronary imaging (ICI) techniques, such as IVUS and OCT, in overcoming the limitations of angiography and guiding percutaneous coronary intervention (PCI).
free
Original Research
Feb 10
Sang Yoon Lee, Joo Myung Lee, et al.
In patients with complex coronary lesions, intravascular imaging-guided PCI showed lower risk of target vessel failure compared to angiography-guided PCI, with greater benefit as the number of complex lesion features increased.
Meet Cory, your AI Assistant!
Learn more
Enhance your reading experience and get deeper insights on complex topics.
Flashlight
Feb 4
Primero Ng, Lorenzo Azzalini, et al.
A 36-year-old man underwent percutaneous coronary intervention of his right coronary artery chronic total occlusion using reverse controlled antegrade and retrograde tracking facilitated by a Ringer perfusion balloon catheter, achieving a good result.
Editorial
Feb 7
Carlos Collet, Takuya Mizukami, et al.
The FAVOR III subanalysis suggests that quantitative flow ratio (QFR) may not be as reliable as invasive fractional flow reserve (FFR) in guiding clinical decision-making for percutaneous coronary intervention in patients with stable coronary artery disease.
free
Original Research
Feb 6
Birgitte K. Andersen, Javier Escaned, et al.
This post-hoc analysis of the FAVOR III Europe trial found that QFR-based deferral of coronary artery revascularization resulted in a higher incidence of 1-year major adverse cardiac events compared to FFR-based deferral, mainly driven by unplanned revascularizations.
State-of-the-Art
Feb 5
Enrico G. Ferro, Robert W. Yeh, et al.
This review analyzes randomized and non-randomized studies on the use of mechanical circulatory support devices in complex, high-risk percutaneous coronary intervention, highlighting the need for standardized algorithms and further research.
free
NEW ISSUE
Feb 3
This issue of EuroIntervention includes a state-of-the-art on the use of mechanical circulatory support in complex, high-risk PCI. In original research, articles on the safety of revascularisation deferral using either QFR or FFR from the FAVOR III Europe trial; outcomes of intravascular imaging-guided PCI according to lesion complexity; outcomes of FFR and IVUS guidance for PCI in patients with or without diabetes. A flashlight on ringer-facilitated reverse CART; international relations of the EAPCI; and more.
Editorial
Jan 31
Stefan Toggweiler
Transcatheter aortic valve implantation (TAVI) complications have declined due to advancements in technology and physician experience, but the increasing number of procedures has strained hospital resources.
free
Original Research
Jan 30
Francesco Bendandi, Francesco Saia et al.
This study developed and validated the D-PACE score to predict high-grade atrioventricular block occurring between 24 hours and 30 days after transcatheter aortic valve implantation. The score can identify low-risk patients suitable for next-day discharge.
free
Trending articles
Intracoronary optical coherence tomography: state of the art and future directions
Computed tomographic angiography in coronary artery disease
Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Management of cardiogenic shock
De-escalation from ticagrelor to clopidogrel in patients with acute myocardial infarction: the TALOS-AMI HBR substudy
Mechanical circulatory support for complex, high-risk percutaneous coronary intervention
Prognostic impact of cardiac damage staging classification in each aortic stenosis subtype undergoing TAVI
Development and validation of the D-PACE scoring system to predict delayed high-grade conduction disturbances after transcatheter aortic valve implantation
Development and validation of the D-PACE scoring system to predict delayed high-grade conduction disturbances after transcatheter aortic valve implantation
Coronary spasm and vasomotor dysfunction as a cause of MINOCA
Targeting inflammation in atherosclerosis: overview, strategy and directions
State-of-the-Art
10.4244/EIJ-D-21-00089
•
Jun 11, 2021
Ali ZA et al
free
State-of-the-Art
10.4244/EIJ-D-22-00776
•
Apr 3, 2023
Serruys PW et al
free
Expert consensus
10.4244/EIJ-D-22-00723
•
Mar 20, 2023
Barbato E et al
free
State-of-the-Art Review
10.4244/EIJ-D-20-01296
•
Aug 27, 2021
Thiele H et al
free
Clinical research
10.4244/EIJ-D-23-00427
•
Dec 4, 2023
Kim MC et al
free
State-of-the-Art
10.4244/EIJ-D-24-00386
•
Feb 3, 2025
Ferro E et al
free
Clinical research
10.4244/EIJ-D-23-00590
•
Dec 4, 2023
Nakase M et al
free
Original Research
10.4244/EIJ-D-24-00850
•
Nov 21, 2024
Bendandi F et al
free
Original Research
10.4244/EIJ-D-24-00850
•
Jan 20, 2025
Bendandi F et al
State-of-the-Art
10.4244/EIJ-D-23-00448
•
Jan 15, 2024
Yaker ZS et al
free
State-of-the-Art
10.4244/EIJ-D-23-00606
•
Jan 1, 2024
Waksman R et al
free
